Benzbromarone, an old uricosuric drug, inhibits human fatty acid binding protein 4 in vitro and lowers the blood glucose level in db/db mice

Pharmacological inhibition of diacylglycerol acyltransferase 1 reduces body weight gain, hyperlipidemia and hepatic steatosis in db/db mice

(2010) Xiao-dong Zhang et al.   ACTA PHARMACOLOGICA SINICA

Discovery of highly selective inhibitors of human fatty acid binding protein 4 (FABP4) by virtual screening

(2010) Haiyan Cai et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

N-Benzyl-indolo carboxylic acids: Design and synthesis of potent and selective adipocyte fatty-acid binding protein (A-FABP) inhibitors

(2009) Tjeerd Barf et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

A Benefit-Risk Assessment of Benzbromarone in the Treatment of Gout

(2009) Ming-Han H Lee et al.   DRUG SAFETY

Identification and Characterization of a Small Molecule Inhibitor of Fatty Acid Binding Proteins

(2009) Ann V. Hertzel et al.   JOURNAL OF MEDICINAL CHEMISTRY

Crystal Structure of the Peroxisome Proliferator-Activated Receptor γ (PPARγ) Ligand Binding Domain Complexed with a Novel Partial Agonist: A New Region of the Hydrophobic Pocket Could Be Exploited for Drug Design

(2008) Roberta Montanari et al.   JOURNAL OF MEDICINAL CHEMISTRY